147 related articles for article (PubMed ID: 9694835)
1. The mannose 6-phosphate/insulin-like growth factor II receptor is a nanomolar affinity receptor for glycosylated human leukemia inhibitory factor.
Blanchard F; Raher S; Duplomb L; Vusio P; Pitard V; Taupin JL; Moreau JF; Hoflack B; Minvielle S; Jacques Y; Godard A
J Biol Chem; 1998 Aug; 273(33):20886-93. PubMed ID: 9694835
[TBL] [Abstract][Full Text] [Related]
2. Mannose 6-Phosphate/Insulin-like growth factor II receptor mediates internalization and degradation of leukemia inhibitory factor but not signal transduction.
Blanchard F; Duplomb L; Raher S; Vusio P; Hoflack B; Jacques Y; Godard A
J Biol Chem; 1999 Aug; 274(35):24685-93. PubMed ID: 10455136
[TBL] [Abstract][Full Text] [Related]
3. Leukemia inhibitory factor (LIF) and oncastsin M (OSM) high affinity binding require additional receptor subunits besides GP130 and GP190.
Heymann D; Godard A; Raher S; Bentouimou N; Blanchard F; Cherel M; Hallet MM; Jacques Y
Cytokine; 1996 Mar; 8(3):197-205. PubMed ID: 8833034
[TBL] [Abstract][Full Text] [Related]
4. Epitope-function relationships of human leukemia inhibitory factor receptors using a novel set of anti-gp190 mAB.
Blanchard F; Pitard V; Taupin JL; Raher S; Hallet MM; Moreau JF; Godard A; Jacques Y
Int Immunol; 1997 Dec; 9(12):1775-84. PubMed ID: 9466305
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the immunoglobulin-like domain of gp190, the leukemia inhibitory factor (LIF) receptor, increase or decrease its affinity for LIF.
Bitard J; Daburon S; Duplomb L; Blanchard F; Vuisio P; Jacques Y; Godard A; Heath JK; Moreau JF; Taupin JL
J Biol Chem; 2003 May; 278(18):16253-61. PubMed ID: 12601009
[TBL] [Abstract][Full Text] [Related]
6. Binding of leukemia inhibitory factor (LIF) to mutants of its low affinity receptor, gp190, reveals a LIF binding site outside and interactions between the two cytokine binding domains.
Taupin JL; Miossec V; Pitard V; Blanchard F; Daburon S; Raher S; Jacques Y; Godard A; Moreau JF
J Biol Chem; 1999 May; 274(20):14482-9. PubMed ID: 10318874
[TBL] [Abstract][Full Text] [Related]
7. High and low affinity receptors for human interleukin for DA cells/leukemia inhibitory factor on human cells. Molecular characterization and cellular distribution.
Godard A; Heymann D; Raher S; Anegon I; Peyrat MA; Le Mauff B; Mouray E; Gregoire M; Virdee K; Soulillou JP
J Biol Chem; 1992 Feb; 267(5):3214-22. PubMed ID: 1737777
[TBL] [Abstract][Full Text] [Related]
8. Binding interactions of leukemia inhibitory factor and ciliary neurotrophic factor with the different subunits of their high affinity receptors.
Robledo O; Auguste P; Coupey L; Praloran V; Chevalier S; Pouplard A; Gascan H
J Neurochem; 1996 Apr; 66(4):1391-9. PubMed ID: 8627290
[TBL] [Abstract][Full Text] [Related]
9. Production and characterization of monoclonal antibodies against the leukemia inhibitory factor low affinity receptor, gp190.
Pitard V; Taupin JL; Miossec V; Blanchard F; Cransac M; Jollet I; Vernallis A; Hudson K; Godard A; Jacques Y; Moreau JF
J Immunol Methods; 1997 Jul; 205(2):177-90. PubMed ID: 9294600
[TBL] [Abstract][Full Text] [Related]
10. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807
[TBL] [Abstract][Full Text] [Related]
11. Separate functions for the two modules of the membrane-proximal cytokine binding domain of glycoprotein 190, the leukemia inhibitory factor low affinity receptor, in ligand binding and receptor activation.
Voisin MB; Bitard J; Daburon S; Moreau JF; Taupin JL
J Biol Chem; 2002 Apr; 277(16):13682-92. PubMed ID: 11834739
[TBL] [Abstract][Full Text] [Related]
12. Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex.
Pennica D; Shaw KJ; Swanson TA; Moore MW; Shelton DL; Zioncheck KA; Rosenthal A; Taga T; Paoni NF; Wood WI
J Biol Chem; 1995 May; 270(18):10915-22. PubMed ID: 7738033
[TBL] [Abstract][Full Text] [Related]
13. Generation of monoclonal antibodies against HILDA/LIF and their use in the quantitative assay of the cytokine.
Godard A; Fauchet F; Raher S; Jadoul M; Thuillier B; Dehart J; Soulillou JP; Baudrihaye M; Jacques Y; De Groote D
Cytokine; 1993 Jan; 5(1):16-23. PubMed ID: 8485303
[TBL] [Abstract][Full Text] [Related]
14. Oncostatin M and leukemia inhibitory factor do not use the same functional receptor in mice.
Ichihara M; Hara T; Kim H; Murate T; Miyajima A
Blood; 1997 Jul; 90(1):165-73. PubMed ID: 9207450
[TBL] [Abstract][Full Text] [Related]
15. Analysis of recombinant soluble mouse D-factor/LIF receptor.
Tomida M
J Biochem; 1995 Jun; 117(6):1228-31. PubMed ID: 7490264
[TBL] [Abstract][Full Text] [Related]
16. Complex binding of leukemia inhibitory factor to its membrane-expressed and soluble receptors.
Layton MJ; Owczarek CM; Metcalf D; Lock PA; Wilson TA; Gough NM; Hilton DJ; Nicola NA
Proc Soc Exp Biol Med; 1994 Jul; 206(3):295-8. PubMed ID: 8016167
[TBL] [Abstract][Full Text] [Related]
17. Leukemia inhibitory factor (LIF), cardiotrophin-1, and oncostatin M share structural binding determinants in the immunoglobulin-like domain of LIF receptor.
Plun-Favreau H; Perret D; Diveu C; Froger J; Chevalier S; Lelièvre E; Gascan H; Chabbert M
J Biol Chem; 2003 Jul; 278(29):27169-79. PubMed ID: 12707269
[TBL] [Abstract][Full Text] [Related]
18. Receptor subunit-specific action of oncostatin M in hepatic cells and its modulation by leukemia inhibitory factor.
Wang Y; Robledo O; Kinzie E; Blanchard F; Richards C; Miyajima A; Baumann H
J Biol Chem; 2000 Aug; 275(33):25273-85. PubMed ID: 10854424
[TBL] [Abstract][Full Text] [Related]
19. Identification of a gp130 cytokine receptor critical site involved in oncostatin M response.
Olivier C; Auguste P; Chabbert M; Lelièvre E; Chevalier S; Gascan H
J Biol Chem; 2000 Feb; 275(8):5648-56. PubMed ID: 10681548
[TBL] [Abstract][Full Text] [Related]
20. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
Schrell UM; Koch HU; Marschalek R; Schrauzer T; Anders M; Adams E; Fahlbusch R
J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
